254 related articles for article (PubMed ID: 36242709)
1. High-risk lesions in the breast diagnosed by MRI-guided core biopsy: upgrade rates and features associated with malignancy.
Cha E; Ambinder EB; Oluyemi ET; Mullen LA; Panigrahi B; Rossi J; Di Carlo PA; Myers KS
Breast Cancer Res Treat; 2022 Dec; 196(3):517-525. PubMed ID: 36242709
[TBL] [Abstract][Full Text] [Related]
2. High-Risk Lesions Detected by MRI-Guided Core Biopsy: Upgrade Rates at Surgical Excision and Implications for Management.
Michaels AY; Ginter PS; Dodelzon K; Naunheim MR; Abbey GN
AJR Am J Roentgenol; 2021 Mar; 216(3):622-632. PubMed ID: 33439046
[No Abstract] [Full Text] [Related]
3. Magnetic resonance imaging-guided core needle breast biopsies resulting in high-risk histopathologic findings: upstage frequency and lesion characteristics.
Weinfurtner RJ; Patel B; Laronga C; Lee MC; Falcon SL; Mooney BP; Yue B; Drukteinis JS
Clin Breast Cancer; 2015 Jun; 15(3):234-9. PubMed ID: 25579460
[TBL] [Abstract][Full Text] [Related]
4. Lobular Neoplasia Diagnosed by MRI-Guided Breast Biopsy: Identifying Upgrade Rate to Malignancy and Outcomes of Clinical and Surgical Management.
Everidge SA; Sun J; Teshome M; Tamirisa N; Sun S; Adesoye T; Nia E; Bevers T; Bedrosian I; Patel M; Singh P
Ann Surg Oncol; 2024 Apr; 31(4):2224-2230. PubMed ID: 38117388
[TBL] [Abstract][Full Text] [Related]
5. Management of high-risk breast lesions diagnosed on core biopsies and experiences from prospective high-risk breast lesion conferences at an academic institution.
Li X; Ma Z; Styblo TM; Arciero CA; Wang H; Cohen MA
Breast Cancer Res Treat; 2021 Feb; 185(3):573-581. PubMed ID: 33068196
[TBL] [Abstract][Full Text] [Related]
6. Surgical upgrade rate of breast atypia to malignancy: An academic center's experience and validation of a predictive model.
Linsk A; Mehta TS; Dialani V; Brook A; Chadashvili T; Houlihan MJ; Sharma R
Breast J; 2018 Mar; 24(2):115-119. PubMed ID: 28833923
[TBL] [Abstract][Full Text] [Related]
7. Atypia Involving Fibroadenomas: Outcomes and Upgrade Rates.
Aripoli A; Winblad O; Balanoff C; Peterson J; Smith C; Huppe A; Hill M; Wermuth D; Gloyeske N
J Breast Imaging; 2024 May; 6(3):254-260. PubMed ID: 38554256
[TBL] [Abstract][Full Text] [Related]
8. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?
Foster MC; Helvie MA; Gregory NE; Rebner M; Nees AV; Paramagul C
Radiology; 2004 Jun; 231(3):813-9. PubMed ID: 15105449
[TBL] [Abstract][Full Text] [Related]
9. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies.
Renshaw AA; Gould EW
Pathology; 2016 Jan; 48(1):25-9. PubMed ID: 27020205
[TBL] [Abstract][Full Text] [Related]
10. Upgrade Rates of Pure, Radiology-Pathology Concordant Lobular Neoplasia Diagnosed on Breast Core Needle Biopsy: Is Surgical Excision Warranted?
Karimi Z; Phillips J; Brook A; Baker G; Guzman Y; Mehta TS
Acad Radiol; 2022 Jul; 29(7):1029-1038. PubMed ID: 34702673
[TBL] [Abstract][Full Text] [Related]
11. High risk breast lesions identified on MRI-guided vacuum-assisted needle biopsy: outcome of surgical excision and imaging follow-up.
Speer ME; Huang ML; Dogan BE; Adrada BE; Candelaria RP; Hess KR; Hansakul P; Yang WT; Rauch GM
Br J Radiol; 2018 Oct; 91(1090):20180300. PubMed ID: 29947265
[TBL] [Abstract][Full Text] [Related]
12. High-risk lesions diagnosed at MRI-guided vacuum-assisted breast biopsy: imaging characteristics, outcome of surgical excision or imaging follow-up.
Okamoto S; Chen ST; Covelli JD; DeMartini WB; Daniel BL; Ikeda DM
Breast Cancer; 2020 May; 27(3):405-414. PubMed ID: 31838725
[TBL] [Abstract][Full Text] [Related]
13. Management of Lobular Neoplasia Diagnosed by Core Biopsy.
Jani C; Lotz M; Keates S; Gupta Y; Walker A; Al Omari O; Parvez A; Patel D; Gnata M; Perry J; Khorashadi L; Weissmann L; Pories SE
Breast J; 2023; 2023():8185446. PubMed ID: 37114120
[TBL] [Abstract][Full Text] [Related]
14. Value of Long-term Follow-up in Surgically Excised Lesions of Uncertain Malignant Potential in the Breast - Is 5 Years Necessary?
Hennessy G; Boland MR; Bambrick M; Crone L; Lloyd A; Abdelwahab S; Downey E; Staunton M; Hambly N; Mhuircheartaigh NN; Kerr J; Power C; Duke D; Hill AD
Clin Breast Cancer; 2022 Oct; 22(7):699-704. PubMed ID: 35732544
[TBL] [Abstract][Full Text] [Related]
15. Outcome of radial scar/complex sclerosing lesion associated with epithelial proliferations with atypia diagnosed on breast core biopsy: results from a multicentric UK-based study.
Rakha E; Beca F; D'Andrea M; Abbas A; Petrou-Nunn W; Shaaban AM; Kandiyil A; Smith S; Menon S; Elsheikh S; ElSayed ME; Lee AH; Sharma N
J Clin Pathol; 2019 Dec; 72(12):800-804. PubMed ID: 31350292
[TBL] [Abstract][Full Text] [Related]
16. Benign breast papillomas without atypia diagnosed with core needle biopsy: Outcome of surgical excision and imaging follow-up.
Polat DS; Knippa EE; Ganti R; Seiler SJ; Goudreau SH
Eur J Radiol; 2020 Oct; 131():109237. PubMed ID: 32905954
[TBL] [Abstract][Full Text] [Related]
17. Surgical and mammographic follow-up of papillary lesions and atypical lobular hyperplasia diagnosed with stereotactic vacuum-assisted biopsy.
Irfan K; Brem RF
Breast J; 2002; 8(4):230-3. PubMed ID: 12100116
[TBL] [Abstract][Full Text] [Related]
18. Upgrade risk of image-targeted radial scar and complex sclerosing lesions diagnosed at needle-guided biopsy: a retrospective study.
Darras C; Uchida M
Eur Radiol; 2023 Dec; 33(12):8399-8406. PubMed ID: 37386299
[TBL] [Abstract][Full Text] [Related]
19. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature.
Elsheikh TM; Silverman JF
Am J Surg Pathol; 2005 Apr; 29(4):534-43. PubMed ID: 15767810
[TBL] [Abstract][Full Text] [Related]
20. Atypical ductal hyperplasia: breast DCE-MRI can be used to reduce unnecessary open surgical excision.
Bertani V; Urbani M; La Grassa M; Balestreri L; Berger N; Frauenfelder T; Boss A; Marcon M
Eur Radiol; 2020 Jul; 30(7):4069-4081. PubMed ID: 32144463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
